Sign in

NCT04943354Completed

Associations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian Failure

Associations of Combinations of Single-nucleotide Polymorphisms and Behavioural Risk Factors With Non-communicable Diseases and Adverse Outcomes in Women With Premature Ovarian Failure

Source: ClinicalTrials.gov · Last updated 12 Mar 2024

Brief summary (registry, in English)

Research objective. \- To study the associations between combinations of single nucleotide polymorphisms and behavioural risk factors with non-communicable diseases and adverse outcomes in women with premature ovarian failure. Research objectives: * To study the associations between combinations of single-nucleotide polymorphisms and behavioural risk factors with heart rate disorders and adverse outcomes in women with premature ovarian failure * Examine the associations between combinations of single nucleotide polymorphisms and behavioural risk factors with stable STIs in women with premature ovarian failure. * Examine the associations between combinations of single nucleotide polymorphisms and behavioural risk factors with thrombomolia in women with premature ovarian failure * Study the associations between combinations of single nucleotide polymorphisms and behavioural risk factors and adverse cardiovascular outcomes in women with premature ovarian failure.

Status (registry)
Completed
Study type
Interventional
Enrollment
238 (actual)
First submitted
27 Nov 2020
Start date
1 Sept 2020
Primary completion date
3 Jun 2022
Lead sponsor
Ryazan State Medical University
NCT number
NCT04943354

What you commit to

  • Study type: Interventional
  • Participants enrolled: 238
  • From 1 Sept 2020 to the primary completion date, 3 Jun 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • age over 45 years

Other

  • male gender

Who the study is looking for

  • women under 45 years old
  • presence of premature ovarian insufficiency in the medical history

Age in the registry: - to 45 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Sergey Vladimirovich Lopukhov
Coordinator of this site? Confirm its status
RyazanRussiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.